Dr. Neil Stuart Freedman, MD

Dr. Freedman practices at Northshore University Healthsystem Faculty Practice Associates in Bannockburn, Illinois.

Dr. Freedman's NPI, 1134112360, was assigned on August 23, 2005. Dr. Freedman graduated from Icahn School Of Medicine At Mount Sinai in 1992. Dr. Freedman holds Illinois license 036100447.

Dr. Freedman's primary practice is Northshore University Healthsystem Faculty Practice Associates, at 2151 Waukegan Rd Ste 100 Suite 100, Bannockburn, IL 60015. The practice phone is (847) 444-5300.

Dr. Freedman's primary practice is Northshore University Healthsystem Faculty Practice Associates in Bannockburn, Illinois. Dr. Freedman is also affiliated with Evanston Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Freedman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freedman practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Freedman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Freedman is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Freedman's licenses on file in 2 states: Illinois and Pennsylvania.

Dmand AI lists acute respiratory failure, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia and respiratory infection and pulmonary fibrosis among the conditions Dr. Freedman treats.

CMS data shows 475 Medicare services from Dr. Freedman across 6 procedure codes in 2024, for 226 Medicare patients. Medicare paid $35,240 for them.

CMS counts 226 Medicare patients who saw Dr. Freedman in 2024. The largest group is 75 to 84, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Freedman's median patient age at 75, with 53% women.

In 2024, Dr. Freedman wrote 739 Medicare Part D claims for 98 patients. 54% of them were for generic drugs. CMS names the drug for 584 of them, across 22 drugs with 11 or more claims each, at $327,602 in total drug cost. In 2023, CMS named 696 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Freedman for performance year 2024, reported as part of a group. Dr. Freedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Freedman, published from 2012 to 2020. 2012 was the busiest year, with 2. The most frequent topics are Polysomnography, Sleep Apnea Syndromes and Sleep Medicine Specialty. Dr. Freedman has published most often in Chest. Dr. Freedman's most frequent co-authors are Ilene Michele Rosen, MD, Douglas B. Kirsch, MD and Barbara Anne Phillips, MD.

CMS Open Payments shows 66 general payments to Dr. Freedman from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,660.

Dmand AI lists 4 awards for Dr. Freedman, most recently Excellence in Education Award in 2016. Dr. Freedman serves on American Board of Internal Medicine (ABIM) Pulmonary Board Exam, Board of Regents American College of Chest Physicians and Finance Committee American College of Chest Physicians.

Dr. Freedman graduated from Icahn School Of Medicine At Mount Sinai in 1992. Dr. Freedman is a member of AASM and ACCP.

Dr. Freedman is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.